Cell Culture Technology– category –
-
AGC Biologics Highlights Strengths as Global CDMO Partner for Biologics and Advanced Therapies
The Economy Global Overview AGC Biologics is recognized as a global biopharmaceutical CDMO providing development and manufacturing services across a wide range of advanced modalities, including biologics, plasmid DNA, mRNA, viral vectors... -
Evonik Invests Over $108 Million in Vancouver GMP Facility, Tripling Lipid-Based Drug Delivery Capacity
bionity.com Canada Overview Evonik announced an investment exceeding CAD 150 million (approximately USD 108 million) into its GMP manufacturing facility in Vancouver, Canada, more than tripling its production capacity for lipid-based dru... -
ProBio Establishes Cell and Gene Therapy CDMO Center of Excellence in Hopewell, New Jersey, Specializing in Plasmid DNA and Viral Vector Manufacturing
ProBio USA Overview ProBio has opened a Cell and Gene Therapy Center of Excellence in Hopewell, New Jersey, focusing on the development and GMP manufacturing of plasmid DNA and viral vectors. This new facility is designed to meet stringe... -
WuXi Biologics Reports 18.4% H1 2026 Revenue Growth and 300 IND Application Capacity Annually, Driven by Low-Cost Strategy
Seeking Alpha China Overview WuXi Biologics announced robust financial results for H1 2026, with revenue increasing by 18.4%, primarily driven by demand for investigational drugs and multi-specific antibodies. The company has expanded it... -
Japan Approves Stem Cell Therapy for Parkinson’s Disease: Kyoto University Research Paves Way for Clinical Application
Facebook (repost of news, citing Kyoto University research) Japan Overview According to news reposts citing Kyoto University research, Japan has approved a stem cell therapy for Parkinson's disease treatment. This approval marks a major ... -
Indian Pharma Accelerates Digital Bioprocessing Adoption: Digital Twins Optimize Bioreactor Performance and Mitigate Scale-Up Risks
BioSpectrum India India Overview Indian pharmaceutical companies are accelerating the adoption of digital bioprocessing tools, with a significant focus on digital twin technology to optimize manufacturing. Digital twins accurately simula... -
Celularity and MuseCell Innovations® Forge US Manufacturing Partnership, Projecting Over $300M in Purchases for Dezawa MuseCell® Platform
Celularity (Press Release) USA Overview Celularity Inc. announced a US manufacturing collaboration with MuseCell Innovations®, with Celularity's Florham Park, NJ facility set to produce Dezawa MuseCells® and related products. This partne... -
Dynamic Perfusion Culture Revolutionizes Monoclonal Antibody Manufacturing: Maximizing Product Quality and Yield, Driving Continuous Biomanufacturing
Bioprocess Online USA Overview While fed-batch remains standard for mAb production, dynamic perfusion culture offers compelling opportunities to boost product quality, yield, and facility utilization by optimizing cell growth and metabol... -
Repurposing Photo Paper for Scalable 3D Biosensing Platform: Breakthrough Low-Cost, Label-Free, Time-Resolved Cell Analysis Achieved
ACS Publications USA Overview Researchers developed a scalable 3D biosensing platform by repurposing off-the-shelf photo paper for label-free, time-resolved cell analysis, overcoming limitations of traditional 3D cell culture. This innov... -
AI and Digital Twins Accelerate Cultivated Meat Commercialization: Bioprocess Optimization Drives Cost Reduction and Productivity
Food Engineering USA Overview A hybrid model digital twin strategy, combining AI with mechanistic bioprocess modeling, is emerging as an indispensable tool for commercially scaling cultivated meat production. These virtual models optimiz...
